<unk>  is an antineoplastic agent that is FDA approved for the treatment of multiple myeloma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include peripheral edema, rash, hypercalcemia,constipation, diarrhea, nausea, anemia,neutropenia,thrombocytopenia,dizziness.
Pomalidomide
Thalidomide
Lenalidomide
Vincristine sulfate
Hydroxyurea
Mafosfamide
Ixazomib
Trimetrexate